| Literature DB >> 32453716 |
Brooke L Latour1, Julie C Van De Weghe2, Tamara Ds Rusterholz3,4, Stef Jf Letteboer1, Arianna Gomez2, Ranad Shaheen5, Matthias Gesemann4, Arezou Karamzade6, Mostafa Asadollahi6, Miguel Barroso-Gil7, Manali Chitre8, Megan E Grout2, Jeroen van Reeuwijk1, Sylvia Ec van Beersum1, Caitlin V Miller2, Jennifer C Dempsey2, Heba Morsy9, Michael J Bamshad2,10,11,12, Deborah A Nickerson10,11, Stephan Cf Neuhauss4, Karsten Boldt13, Marius Ueffing13, Mohammad Keramatipour6, John A Sayer7, Fowzan S Alkuraya5,14, Ruxandra Bachmann-Gagescu3,4, Ronald Roepman1, Dan Doherty2,15.
Abstract
Joubert syndrome (JBTS) is a recessive neurodevelopmental ciliopathy characterized by a pathognomonic hindbrain malformation. All known JBTS genes encode proteins involved in the structure or function of primary cilia, ubiquitous antenna-like organelles essential for cellular signal transduction. Here, we used the recently identified JBTS-associated protein armadillo repeat motif-containing 9 (ARMC9) in tandem-affinity purification and yeast 2-hybrid screens to identify a ciliary module whose dysfunction underlies JBTS. In addition to the known JBTS-associated proteins CEP104 and CSPP1, we identified coiled-coil domain containing 66 (CCDC66) and TOG array regulator of axonemal microtubules 1 (TOGARAM1) as ARMC9 interaction partners. We found that TOGARAM1 variants cause JBTS and disrupt TOGARAM1 interaction with ARMC9. Using a combination of protein interaction analyses, characterization of patient-derived fibroblasts, and analysis of CRISPR/Cas9-engineered zebrafish and hTERT-RPE1 cells, we demonstrated that dysfunction of ARMC9 or TOGARAM1 resulted in short cilia with decreased axonemal acetylation and polyglutamylation, but relatively intact transition zone function. Aberrant serum-induced ciliary resorption and cold-induced depolymerization in ARMC9 and TOGARAM1 patient cell lines suggest a role for this new JBTS-associated protein module in ciliary stability.Entities:
Keywords: Genetic diseases; Genetics; Proteomics
Mesh:
Substances:
Year: 2020 PMID: 32453716 PMCID: PMC7410078 DOI: 10.1172/JCI131656
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808